Answers are grounded in this paper and cite their sources.
CD3ζ, encoded by SLE susceptibility gene CD247, is essential for TCR signaling and T cell responses. While genetically linked to systemic lupus erythematosus (SLE), its role in SLE progression remains unclear. Flow cytometry quantified CD4⁺CD3ζdim T-cell frequencies and IFN-γ production in patients with SLE and lupus mouse models. A genetic model with reduced CD3ζ expression in the CD4 lineage was evaluated in resiquimod- and pristane-induced lupus. Changes associated with mesenchymal stromal cell transplantation (MSCT) were assessed in lupus mice. Co-immunoprecipitation and protein degradation assays investigated CD3ζ regulation and the effects of MSC-derived extracellular vesicles (MSC-EVs) in vitro. CD4⁺CD3ζdim T-cell frequencies were increased in patients with SLE and lupus mice. These cells exhibited greater IFN-γ production than CD4⁺CD3ζbright T cells. Mice with CD4-lineage CD3ζ reduction showed more severe induced lupus manifestations, including increased B-cell and plasmablast responses and exacerbated proteinuria. MSCT-treated mice showed improved disease manifestations, accompanied by lower CD4⁺CD3ζdim T-cell frequencies and reduced IFN-γ production. In vitro, TRIM21 associated with CD3ζ and was implicated in the negative regulation of its protein abundance. TRIM21 expression was inversely associated with CD3ζ expression in lupus and MSC-EVs increased CD3ζ protein expression and modulated TRIM21 in vitro. CD4⁺CD3ζdim T cells are more frequent in patients with SLE and lupus mice and exhibit greater IFN-γ production than CD4⁺CD3ζbright T cells. Mice with genetically reduced CD3ζ expression in the CD4 lineage exhibit aggravated disease manifestations following resiquimod or pristane induction. MSCT-treated mice show improved lupus manifestations and reduced TRIM21 expression. In vitro findings support the involvement of TRIM21 in regulating CD3ζ abundance and show that MSC-EVs increase CD3ζ protein expression. CD4⁺CD3ζdim T-cell frequencies are increased in patients with SLE and lupus-prone mice. CD4⁺ T-cell-specific CD3ζ knockdown aggravates resiquimod- and pristane-induced lupus. CD4⁺CD3ζdim T cells produce more IFN-γ than CD4⁺CD3ζbright T cells. MSCT ameliorates murine lupus, accompanied by lower CD4⁺CD3ζdim T-cell frequencies and reduced IFN-γ production. MSC-EVs increase CD3ζ protein expression in vitro, with TRIM21 implicated in this regulation.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: